A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Estrone Acetate | CAS 901-93-9 - Request Quote

Picture of Estrone Acetate

Estrone Acetate

SZ CAT No:SZ-E031018
CAS No
901-93-9
Mol.F.
C20H24O3
Mol.Wt.
312.4
Inv. Status
In Stock

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Estrone Acetate is chemically (8R,9S,13S,14S)-13-Methyl-17-oxo-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl acetate. Estrone Acetate is supplied with detailed characterization data compliant with regulatory guideline. Estrone Acetate can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Estradiol.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 901-93-9

Purchase 901-93-9

Order 901-93-9

Enquire 901-93-9

price of 901-93-9

901-93-9 Supplier

901-93-9 Manufacturer

901-93-9 Exporter

buy high quality Estrone Acetate

Purchase Estrone Acetate

Estrone Acetate suppliers

Estrone Acetate manufacturers

Estrone Acetate price

Order Estrone Acetate

Enquire Estrone Acetate

Estrone Acetate cost

Estrone Acetate Supplier

Estrone Acetate Distributor

Estrone Acetate for Method Validation

Estradiol Reference Standard

Estrone Acetate for ANDA Filing

Estrone Acetate for Forced Degradation Studies

Estrone Acetate Identification Standards

Estrone Acetate for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,